Grant appendices are read by people who may not know the difference between a catalogue peptide and a medicinal product. That is why the paperwork must do the distinguishing work before a reviewer, finance officer or materials manager has to guess. A research peptide supplied for controlled in-vitro work is a laboratory material. A licensed medicine is a product with a specific regulatory status, authorised clinical use and accompanying medicinal documentation. Mixing those categories in an appendix creates avoidable risk: reviewers may question compliance, procurement may stall, and the scientific rationale can be obscured by imprecise language. The aim is not to make a research material sound clinical. It is to make its non-clinical, research-use-only status unmistakable.
Start with the Regulatory Label, Not the Product Name
Product names can mislead. The word peptide appears in research catalogues and in licensed medicines, and some familiar names carry clinical associations that do not apply to a laboratory reagent. A grant appendix should therefore begin with regulatory status, not with a trade name or a shorthand category. Write that the item is a research-use-only material for controlled in-vitro laboratory work; state clearly that it is not a medicine, medical device, injectable, treatment or food supplement under UK law; and repeat that it is not for human or veterinary use. Research Sciences describes its products as strictly for controlled laboratory and analytical research, and states that products are labelled “For Research Use Only – Not for Human Consumption”, in line with MHRA guidance as the shop’s stated position. That wording should be presented as supplier documentation, not as legal advice.
By contrast, a licensed medicine in grant paperwork would normally be identified through its UK marketing authorisation, product licence number, Summary of Product Characteristics, patient information and authorised clinical indication. Those are medicinal-product documents. A research peptide appendix should not imitate them. Its evidence base is different: supplier label, batch certificate of analysis, storage statement, risk assessment, COSHH considerations and a clear in-vitro experimental rationale. A catalogue item such as a lyophilised Peptide uk research material should be introduced as an RUO laboratory reagent, not as a medicine with a clinical use.
Vocabulary that belongs in the appendix
Use research material, research peptide, analytical reference material where accurate, and in-vitro study material where the workflow is laboratory-based. Avoid “medicine”, “medicinal product”, “treatment”, “therapy” and “drug” except when explicitly contrasting the research material with a licensed medicine. Do not describe an in-vitro concentration as a dose. Do not imply that a supplier’s catalogue listing has clinical status. The reviewer should be able to find a short regulatory-status statement on the first page of the appendix and see the same language repeated in the item table, budget justification and handling notes.
Documenting Batch Identity, Testing and Storage Without Overclaiming
Grant reviewers and materials managers need traceability, but they do not need promotional language. The appendix should identify the supplier, catalogue item, form, batch reference and the certificate of analysis that accompanies the specific batch. Research Sciences states that every compound includes a CoA for purity and identity, with HPLC testing described in its FAQs, and the homepage lists “CoAs Janoshik Analytical Reports”. If that statement is used, attribute it to the supplier’s current published wording and tell readers to open and check the CoA for the actual batch. The homepage also publishes figures such as “≥99% Verified Purity” and “UK Research Materials Over 99.1% Purity”. Do not treat those as your own analytical result. Say that the supplier currently publishes those figures and that purity and identity should be reconfirmed on the batch CoA.
Batch labels matter. Research Sciences describes vial labels that combine a SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. The appendix can quote that reference when contacting the supplier about documentation. The FAQs also explain that restocked products may carry the same Internal Test Reference as earlier stock; an ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. That nuance belongs in the appendix if restocked material is used. Similarly, cap colour is not an indicator of identity, analytical quality or manufacturing origin. The paperwork should rely on the label reference and CoA, not on packaging appearance.
Handling statements for in-vitro workflows
Storage and handling notes should be practical and clearly laboratory-focused. The supplier’s quick guide describes allowing vials to reach room temperature before opening, working in a clean environment, removing only the amount required for the experiment, and storing lyophilised peptides at −20°C or below, sealed with desiccant and protected from moisture, heat and light. It advises avoiding repeated freeze–thaw cycles and storing reconstituted peptides at 2–8°C for short-term laboratory use. In an appendix, reconstitution should be described only as an in-vitro step: diluent volume and concentration for the assay, prepared within the laboratory workflow. The supplier’s reconstitution calculator is for laboratory research use only and must not be used for human or veterinary dosing. Repeat the RUO statement in the handling section: materials are not for human or veterinary use.
Building an Audit-Ready Appendix for Reviewers and Materials Managers
An audit-ready appendix is not a catalogue dump. It is a controlled cross-reference. Start with a cover sheet that states the regulatory category, the intended in-vitro use, the responsible investigator and the laboratory in which the work will take place. Follow with an item table listing supplier, catalogue name, form, batch reference, CoA availability, storage condition and disposal route. Add a short note on COSHH and laboratory safety, because the purchaser is responsible for lawful use, safe handling, storage and disposal. Where the work involves UK laboratories, local safety arrangements should be visible without turning the appendix into an unverified compliance certificate. The aim is to show that the materials manager can receive, store and account for the material under controlled conditions.
Procurement language also needs care. The homepage uses a “24hr UK Delivery” marketing line, but the supplier’s FAQ describes dispatch the next working day via Royal Mail Tracked 24, which usually delivers the following working day as a Royal Mail estimate. Delivery times are estimates and may vary in peak periods. A grant appendix should not convert that into a guaranteed arrival promise. State the published fulfilment terms, attribute them to the supplier’s current wording and reconfirm at checkout. Also note that returns are not accepted once dispatched because of the specialist and perishable nature of the goods, with refunds only for damage, incorrect supply or quality issues as set out in the Refunds & Returns Policy.
A reviewer-friendly cross-reference
A useful test is to imagine a reviewer searching the appendix for the word “medicine”. Every occurrence should be part of an explicit contrast, not an accidental description. If a budget justification says “peptide medicine”, correct it to “research peptide for in-vitro assay”. If a materials manager sees a clinical-sounding product name, the appendix should point them to the RUO label, the batch CoA and the risk assessment. One short case example can help: a reviewer queries whether a listed peptide is a therapeutic agent; the appendix shows the supplier’s RUO statement, the batch-specific CoA and the laboratory’s in-vitro protocol, so the question is answered without upgrading the material into a medicine. That is the standard the paperwork should meet: precise, traceable and consistently research-use-only. Materials are not for human or veterinary use, and every appendix statement should make that boundary easy to find.
Granada flamenco dancer turned AI policy fellow in Singapore. Rosa tackles federated-learning frameworks, Peranakan cuisine guides, and flamenco biomechanics. She keeps castanets beside her mechanical keyboard for impromptu rhythm breaks.